鼻咽癌IMRT后3个月MRI检出残留咽后淋巴结的预后价值及治疗前预测列线图
研究纳入两家医院共1103例鼻咽癌患者,评估IMRT后3个月MRI检出残留咽后淋巴结(RRLN)的预后价值,并基于EBV DNA和淋巴结特征建立治疗前预测RRLN的列线图。RRLN是OS、DFS、DMFS和LRRFS的独立不良预后因素,列线图在训练队列C-index为0.763,并在内部和外部验证队列中表现良好。
要点
- IMRT后3个月MRI检出RRLN是鼻咽癌独立不良预后因素。
- 基于EBV DNA和淋巴结特征的列线图可治疗前预测RRLN风险。
- 列线图区分度良好,训练队列C-index为0.763,内外验证均确认。
核心结论
- IMRT后3个月MRI检出的残留咽后淋巴结是鼻咽癌患者的不良预后因素。
- 基于治疗前EBV DNA水平和三个咽后淋巴结特征建立的列线图可预测RRLN风险,并已在内部和外部验证。
研究设计与样本
- 回顾性纳入两家医院共1103例鼻咽癌患者,其中中山大学肿瘤防治中心901例,东莞市人民医院202例。
- 在中山大学肿瘤防治中心队列用Cox回归评估RRLN预后价值,用logistic回归在训练队列(n=645)建立列线图,并在内部验证队列(n=256)和外部独立队列(n=202)评估性能。
主要发现
- RRLN是OS的独立预后因素(HR 2.08,95%CI 1.32-3.29)。
- RRLN是DFS的独立预后因素(HR 2.45,95%CI 1.75-3.42)。
- RRLN是DMFS的独立预后因素(HR 3.31,95%CI 2.15-5.09)。
- RRLN是LRRFS的独立预后因素(HR 3.04,95%CI 1.70-5.42)。
- 列线图在训练队列区分度良好(C-index=0.763),内部和外部验证队列均确认其良好性能。
关键数值与推荐
- 列线图基于基线EBV DNA水平和三个咽后淋巴结状态相关特征:最小轴径、结外侵犯和侧别。
- 训练队列C-index为0.763,内部验证队列n=256,外部独立验证队列n=202。
临床怎么用
- 对鼻咽癌患者IMRT后3个月MRI检出RRLN者,应认识到其OS、DFS、DMFS和LRRFS较差的风险。
- 治疗前可使用基于EBV DNA和咽后淋巴结特征的列线图预测RRLN风险,辅助个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To evaluate the prognostic value of MRI-detected residual retropharyngeal lymph node (RRLN) at three months after intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC) and second, to establish a nomogram for the pretherapy prediction of RRLN. MATERIALS AND METHODS: We included 1103 patients with NPC from two hospitals (Sun Yat-Sen University Cancer Center [SYSUCC, n = 901] and Dongguan People's Hospital [DGPH, n = 202]). We evaluated the prognostic value of RRLN using Cox regression model in SYSUCC cohort. We developed a nomogram for the pretherapy prediction of RRLN using logistic regression model in SYSUCC training cohort (n = 645). We assessed the performance of this nomogram in an internal validation cohort (SYSUCC validation cohort, n = 256) and an external independent cohort (DGPH validation cohort, n = 202). RESULTS: RRLN was an independent prognostic factor for OS (HR 2.08, 95% CI 1.32-3.29), DFS (HR 2.45, 95% CI 1.75-3.42), DMFS (HR 3.31, 95% CI 2.15-5.09), and LRRFS (HR 3.04, 95% CI 1.70-5.42). We developed a nomogram based on baseline Epstein-Barr virus DNA level and three RLN status-related features (including minimum axial diameter, extracapsular nodal spread, and laterality) that predicted an individual's risk of RRLN. Our nomogram showed good discrimination in the training cohort (C-index = 0.763). The favorable performance of this nomogram was confirmed in the internal and external validation cohorts. CONCLUSION: MRI-detected RRLN at three months after IMRT was an unfavorable prognostic factor for patients with NPC. We developed and validated an easy-to-use nomogram for the pretherapy prediction of RRLN.
引用
- Li WZ, Liu GY, Lin LF, et al. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it. Radiother Oncol. 2020. PMID: 31931288. doi:10.1016/j.radonc.2019.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。